Post by GSK

We have topped the Access to Medicine Foundation’s 2026 Antimicrobial Resistance (#AMR) Benchmark among large biopharma companies.    Antimicrobial resistance is one of the most pressing scientific and medical challenges of our time. More than one million people die each year as a direct result of drug-resistant infections    This leading position reflects our continuous focus on delivering innovative antibiotic medicines and vaccines for patients where there is significant unmet medical need.    To learn more, tune in to our ‘Behind the Science’ podcast episode ‘Are we turning the tide on superbugs?’: https://pod.fo/e/380f82